ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Recombinant Anti-IL-8 Antibody [B-B49] - BSA and Azide free (A342126)

Recombinant mouse monoclonal [B-B49] IVD antibody to IL-8 for ELISA.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-IL-8 Antibody [B-B49] - BSA and Azide free
Description
Recombinant mouse monoclonal [B-B49] IVD antibody to IL-8.
Specificity
This product recognizesboth natural and recombinant human IL-8.
Applications
ELISA
Reactivity
Human
Immunogen
Recombinant human IL-8.
Host
Mouse
Clonality
Monoclonal
Clone ID
B-B49
Myeloma
Source: Recombinant antibody from a phage display library
Isotype
Mouse IgG1 Kappa light chain
Conjugate

Unconjugated

Concentration
1.0 mg/mL (+/- 10 %)
Product Form
Liquid
Formulation
Phosphate-buffered saline. Sterile-filtered through 0.22µm. Carrier and preservative free.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
C-X-C motif chemokine 8, C-X-C motif) ligand 8, Chemokine, CXCL8, Emoctakin, GCP-1, Granulocyte chemotactic protein 1, IL8, Interleukin-8, MDNCF, Monocyte-derived neutrophil chemotactic factor
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Anti-IL-8 Antibody [B-B49] - BSA and Azide free (A342126)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-IL-8 Antibody [B-B49] - BSA and Azide free (A342126)

Proteins predicted to interact with IL-8

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
99.7% Relevancy Score
99.7% Relevancy Score